GO:0043414 macromolecule methylation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043414 macromolecule methylation is the covalent attachment of a methyl residue to a polypeptide, polynucleotide, polysaccharide, or other biological macromolecule.
• Methylation of macromolecules is a central epigenetic and epitranscriptomic mechanism that regulates chromatin compartmentalization, RNA stability, and protein function.
• Histone methylation contributes to phase separation and chromatin compartmentalization, influencing gene expression programs.
• Internal RNA 2'-O-methylation on the HIV-1 genome impairs reverse transcription, showing direct antiviral relevance of macromolecule methylation.
• RNA-modifying proteins, including methyltransferases, are emerging as anticancer drug targets.
• Epi-miRNAs mediate methylation status in human cancers, linking macromolecule methylation to tumor biology.
Description
Macromolecule methylation (GO:0043414) is a fundamental biological process defined as the covalent attachment of a methyl residue to one or more monomeric units in a polypeptide, polynucleotide, polysaccharide, or other biological macromolecule. This broad ontology term encompasses methylation events on proteins, nucleic acids, and complex carbohydrates, making it a central node in epigenetic, epitranscriptomic, and post-translational regulatory networks. Researchers study macromolecule methylation because it controls chromatin architecture, RNA fate, protein-protein interactions, and cellular responses to environmental cues. In cancer biology, methylation of macromolecules is frequently dysregulated, and epi-miRNAs that modulate methylation status have been implicated in tumor progression. In virology, internal RNA 2'-O-methylation on the HIV-1 genome directly impairs reverse transcription, highlighting the functional consequence of a single methyl mark on a polynucleotide. The breadth of GO:0043414 makes it a critical term for understanding how cells encode and transmit regulatory information beyond the primary sequence of DNA, RNA, and proteins.
macromolecule methylation At A Glance
| GO ID | GO:0043414 |
|---|---|
| GO term | macromolecule methylation |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Covalent attachment of a methyl residue to polypeptides, polynucleotides, polysaccharides, or other biological macromolecules |
| Substrate scope | Proteins, RNA, DNA, polysaccharides, and other macromolecules |
| Cellular context | Nuclear and cytoplasmic compartments; chromatin, RNA processing, and protein regulation |
| Related processes | Epigenetic regulation, epitranscriptomics, post-translational modification, chromatin compartmentalization |
| Disease relevance | Cancer, viral infection, aging, and metabolic disorders |
What Is GO:0043414?
In our own words, macromolecule methylation (GO:0043414) is the enzymatic or non-enzymatic addition of a methyl group (-CH3) to a large biological molecule such as a protein, RNA, DNA, or polysaccharide. This modification can occur on amino acid side chains in polypeptides, on nucleotide bases or the ribose 2'-O position in polynucleotides, or on sugar hydroxyl groups in polysaccharides. The QuickGO definition emphasizes that the methyl residue is covalently attached to one or more monomeric units within the macromolecule, distinguishing it from small-molecule methylation or free methyl group transfer.
Why Is macromolecule methylation Important in Cell Biology?
Macromolecule methylation is important because it provides a reversible and highly specific mechanism for cells to regulate the function of proteins, RNA, and DNA without changing their primary sequence. This process is essential for chromatin compartmentalization, as histone modifications including methylation contribute to phase separation mechanisms that organize the genome. In RNA biology, methylation of the HIV-1 genome at internal 2'-O positions impairs reverse transcription, demonstrating that methylation can directly restrict viral replication. Furthermore, RNA-modifying proteins that catalyze methylation are being pursued as anticancer drug targets, underscoring the therapeutic potential of understanding GO:0043414. Epi-miRNAs that mediate methylation status in human cancers further link this process to tumor biology and clinical outcomes.
• Regulates chromatin compartmentalization through histone methylation and phase separation.
• Controls RNA stability, translation, and viral reverse transcription via 2'-O-methylation.
• Provides a reversible epigenetic mark that influences gene expression programs.
• Is dysregulated in human cancers, where epi-miRNAs modulate methylation status.
• Represents a druggable pathway, with RNA-modifying proteins as anticancer targets.
• Affects aging-related processes through methylation of macromolecules.
• Influences folate metabolism and one-carbon transfer in bifidobacteria and other organisms.
• Can be studied using CRISPR knockout, point mutation, and knock-in models for causal gene analysis.
• Serves as a biomarker for disease states when methylation patterns are profiled.
• Connects to polysaccharide and polymer chemistry through methyl group attachment.
What Happens During macromolecule methylation?
Substrate recognition and methyltransferase recruitment
In simple terms: First, the cell identifies which macromolecule needs a methyl group and brings in the enzyme that adds it.
Macromolecule methylation begins with the recognition of a specific substrate, such as a histone tail, an RNA motif, or a polysaccharide chain, by a methyltransferase enzyme. For histone methylation, the enzyme recognizes specific residues and contributes to chromatin compartmentalization through phase separation mechanisms. In RNA methylation, internal 2'-O-methylation on the HIV-1 genome requires recognition of specific viral RNA sequences. The recruitment of methyltransferases is often guided by adaptor proteins, non-coding RNAs, or pre-existing chromatin marks.
Methyl group transfer from SAM
In simple terms: The enzyme takes a methyl group from a donor molecule and attaches it to the target macromolecule.
Most macromolecule methylation reactions use S-adenosylmethionine (SAM) as the methyl donor, transferring the methyl group to a nitrogen, oxygen, or carbon atom on the substrate. This covalent attachment is the defining chemical step of GO:0043414. For RNA 2'-O-methylation, the methyl group is added to the ribose 2'-hydroxyl, which can impair reverse transcription of the HIV-1 genome. In proteins, methylation occurs on lysine and arginine residues, affecting interactions and phase behavior.
Chromatin compartmentalization and phase separation
In simple terms: Methyl marks on histones help organize DNA into distinct compartments inside the nucleus.
Histone modifications, including methylation, regulate chromatin compartmentalization by contributing to phase separation mechanisms. This means that methylated histone tails can promote the formation of liquid-like condensates that separate active and inactive genomic regions. Such compartmentalization is essential for gene regulation, DNA repair, and replication. Disruption of this process can lead to aberrant gene expression and disease.
Epitranscriptomic methylation and RNA fate
In simple terms: Methyl groups on RNA change how the RNA is read, translated, or degraded.
Methylation of RNA, particularly 2'-O-methylation, affects RNA stability, translation efficiency, and innate immune recognition. Internal RNA 2'-O-methylation on the HIV-1 genome impairs reverse transcription, showing that this modification can directly block a key viral replication step. RNA-modifying proteins that deposit or remove methyl marks are considered anticancer drug targets because they influence mRNA processing and translation. Epi-miRNAs can also modulate methylation status in cancers, linking RNA methylation to tumor biology.
Methylation in polysaccharides and other macromolecules
In simple terms: Methyl groups can also be added to sugars and synthetic polymers, changing their physical properties.
Beyond proteins and nucleic acids, macromolecule methylation includes the methylation of polysaccharides and other biological macromolecules. In polymer chemistry, methylation of poly(oxazoline)s and oligoethylene glycols alters thermoresponsive behavior and solubility. These chemical modifications are relevant to biomaterials and drug delivery, although the biological process GO:0043414 primarily focuses on enzymatic methylation in living systems.
Key Genes Involved in GO:0043414 macromolecule methylation
The following genes and proteins are experimentally implicated in macromolecule methylation, including methyltransferases, demethylases, and regulatory factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EHMT2 (G9a) | Histone lysine methyltransferase | Catalyzes H3K9 methylation; studied in chromatin compartmentalization |
| SUV39H1 | Histone methyltransferase | Deposits H3K9me3; linked to heterochromatin phase separation |
| EZH2 | Histone methyltransferase | Part of PRC2; methylates H3K27; target in cancer |
| SETD2 | Histone methyltransferase | Methylates H3K36; associated with RNA processing |
| METTL3 | RNA methyltransferase | Catalyzes m6A methylation; anticancer target |
| METTL14 | RNA methyltransferase | Part of m6A writer complex; regulates RNA fate |
| FTO | RNA demethylase | Removes m6A; linked to obesity and cancer |
| ALKBH5 | RNA demethylase | Erases m6A; affects RNA stability |
| Fibrillarin (FBL) | 2'-O-methyltransferase | Catalyzes rRNA 2'-O-methylation; relevant to HIV-1 RNA methylation |
| NSUN2 | RNA m5C methyltransferase | Methylates tRNA and mRNA; role in cancer |
| DNMT1 | DNA methyltransferase | Maintains DNA methylation; epigenetic regulator |
| DNMT3A | DNA methyltransferase | De novo DNA methylation; mutated in cancers |
| PRMT5 | Protein arginine methyltransferase | Methylates histones and splicing factors; anticancer target |
| CARM1 | Protein arginine methyltransferase | Methylates histone H3R17; transcriptional coactivator |
| KMT2A (MLL1) | Histone lysine methyltransferase | Methylates H3K4; involved in leukemia |
| KDM1A (LSD1) | Histone demethylase | Removes H3K4 methylation; drug target |
| Epi-miRNA cluster (e.g., miR-29) | Modulates methylation enzymes | Mediates methylation status in human cancers |
How Is macromolecule methylation Regulated?
Macromolecule methylation is regulated at multiple levels, including the expression and activity of methyltransferases and demethylases, availability of the methyl donor SAM, and interactions with chromatin or RNA-binding proteins. Histone methylation contributes to phase separation and chromatin compartmentalization, which in turn can feedback on methyltransferase recruitment. Epi-miRNAs can modulate the expression of methylation-related enzymes, thereby influencing global methylation status in cancer cells. RNA-modifying proteins are subject to regulation by cellular stress, metabolic cues, and oncogenic signaling, making macromolecule methylation a dynamic process. Folate metabolism and one-carbon transfer, as studied in bifidobacteria, also affect methyl donor availability and thus methylation capacity.
macromolecule methylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EZH2 | Cancer (lymphoma, breast, prostate) | Knockout and point-mutation cell lines to study H3K27me3 loss |
| METTL3 | Acute myeloid leukemia, solid tumors | Overexpression and knockout models to assess m6A effects |
| FTO | Obesity, cancer | Point-mutation knock-in to dissect demethylase activity |
| Fibrillarin (FBL) | HIV-1 infection | Knockout cells to test 2'-O-methylation and reverse transcription |
| DNMT3A | Myelodysplastic syndrome, leukemia | Knock-in of patient mutations to study DNA methylation |
Macromolecule methylation in cancer
Dysregulation of macromolecule methylation is a hallmark of many cancers. Epi-miRNAs that mediate methylation status contribute to tumor progression by altering the expression of methyltransferases and demethylases. RNA-modifying proteins, including METTL3, FTO, and ALKBH5, are being pursued as anticancer drug targets because they control m6A methylation and downstream oncogenic pathways. Histone methylation changes, such as altered H3K27me3 by EZH2, are linked to chromatin compartmentalization defects and aberrant gene silencing in cancer.
Viral infection and RNA methylation
Internal RNA 2'-O-methylation on the HIV-1 genome impairs reverse transcription, demonstrating that methylation of viral RNA can restrict infection. This finding suggests that manipulating RNA methylation pathways could be a therapeutic strategy against HIV-1 and potentially other RNA viruses. The enzymes responsible for 2'-O-methylation, such as fibrillarin, are therefore of interest as host factors in viral replication.
Aging and metabolic disorders
Genes of aging include those involved in methylation and one-carbon metabolism, linking macromolecule methylation to age-related phenotypes. Folate-producing bifidobacteria influence host methylation capacity through one-carbon metabolism, suggesting a microbiome contribution to methylation status. These connections highlight the broad physiological relevance of GO:0043414 beyond cancer and infection.
From macromolecule methylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a methyltransferase affect chromatin compartmentalization? | CRISPR knockout of EHMT2 or SUV39H1 followed by imaging |
| Does a specific methylation site on HIV-1 RNA control reverse transcription? | Point mutation of the 2'-O-methylation site in viral genome |
| Can a disease-associated mutation in DNMT3A alter methylation patterns? | Knock-in of the mutation in cell lines |
| What is the role of METTL3 in cancer cell proliferation? | Overexpression and knockout models |
| How do epi-miRNAs regulate methylation enzymes? | Knockout of miRNA clusters and RNA-seq |
| Does folate metabolism affect global methylation? | Bifidobacteria co-culture and methylation profiling |
How to Study the macromolecule methylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| MeRIP-seq | RNA methylation sites (m6A) | Mapping epitranscriptomic marks |
| Bisulfite sequencing | DNA methylation patterns | Epigenetic profiling in cancer |
| Mass spectrometry | Global methylation levels | Quantifying histone and RNA methylation |
| RiboMeth-seq | 2'-O-methylation sites on rRNA | Studying HIV-1 RNA methylation |
| Hi-C | Chromatin compartmentalization | Linking histone methylation to 3D genome |
| CRISPR knockout screen | Gene essentiality for methylation | Identifying methyltransferase dependencies |
| In vitro methyltransferase assay | Enzyme activity and kinetics | Drug target validation |
Methylation-specific sequencing and mass spectrometry
Researchers use bisulfite sequencing for DNA methylation, MeRIP-seq for RNA methylation, and mass spectrometry for global methylation profiling. These methods quantify methyl marks on macromolecules and identify sites of modification. For 2'-O-methylation, specialized approaches such as RiboMeth-seq or primer extension assays can map sites.
Chromatin conformation and imaging
To study chromatin compartmentalization driven by histone methylation, researchers use Hi-C, super-resolution imaging, and phase separation assays. These techniques reveal how methylated histones contribute to the formation of distinct nuclear compartments. Live-cell imaging of methyltransferase recruitment provides dynamic information.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for macromolecule methylation and its downstream effects. Focused screens targeting methyltransferases, demethylases, and RNA-modifying proteins reveal vulnerabilities in cancer cells. These screens are complemented by transcriptomic and proteomic readouts.
Biochemical assays for methyltransferase activity
In vitro methyltransferase assays using recombinant enzymes and radiolabeled SAM measure catalytic activity and substrate specificity. These assays help determine the kinetic parameters of enzymes involved in GO:0043414. Inhibitor screening can identify small molecules that block methylation.
How CRISPR Can Be Used to Study GO:0043414 macromolecule methylation
Knockout
CRISPR knockout of methyltransferase genes such as EHMT2, SUV39H1, or METTL3 allows researchers to determine their causal role in macromolecule methylation and downstream phenotypes. Knockout cell lines can be used to assess changes in chromatin compartmentalization, RNA stability, and cancer cell growth.
Point Mutation
Point mutations can be introduced into catalytic residues of methyltransferases or into specific methylation sites on RNA or DNA to dissect their function. For example, mutating the 2'-O-methylation site on the HIV-1 genome can test its role in reverse transcription. Point mutations in DNMT3A can model disease-associated variants.
Knock-in
Knock-in of tagged methyltransferases or disease-relevant mutations enables tracking of methylation dynamics and modeling of human disorders. Tagged knock-in lines can be used for chromatin immunoprecipitation or live-cell imaging. Knock-in of patient mutations in DNMT3A or EZH2 helps study oncogenic mechanisms.
Overexpression
Overexpression of methyltransferases or demethylases can reveal gain-of-function effects on macromolecule methylation and cellular phenotypes. Overexpression models are useful for testing whether increased methylation drives proliferation or drug resistance. They complement knockout studies to establish causality.
How EDITGENE Supports macromolecule methylation Research
Researchers studying macromolecule methylation-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations, from knockout to point mutation, knock-in, and overexpression, to support mechanistic studies of GO:0043414.
Contact EDITGENE today to design your custom CRISPR model for macromolecule methylation research.
Frequently Asked Questions About macromolecule methylation
What is macromolecule methylation GO:0043414?
Macromolecule methylation (GO:0043414) is the covalent attachment of a methyl residue to one or more monomeric units in a polypeptide, polynucleotide, polysaccharide, or other biological macromolecule.
What genes are involved in macromolecule methylation?
Key genes include histone methyltransferases such as EHMT2, SUV39H1, and EZH2, RNA methyltransferases such as METTL3 and METTL14, demethylases such as FTO and ALKBH5, and DNA methyltransferases such as DNMT1 and DNMT3A.
How does macromolecule methylation regulate chromatin?
Histone methylation contributes to chromatin compartmentalization by promoting phase separation, which organizes active and inactive genomic regions.
What is the role of RNA 2'-O-methylation in HIV-1?
Internal RNA 2'-O-methylation on the HIV-1 genome impairs reverse transcription, restricting viral replication.
Is macromolecule methylation a drug target in cancer?
Yes, RNA-modifying proteins that catalyze methylation are being pursued as anticancer drug targets, and epi-miRNAs that modulate methylation status are implicated in human cancers.
What methods are used to study macromolecule methylation?
Common methods include MeRIP-seq, bisulfite sequencing, mass spectrometry, RiboMeth-seq, Hi-C, and CRISPR screens.
How can CRISPR be used to study macromolecule methylation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of methylation-related genes and their roles in disease.
What diseases are linked to macromolecule methylation?
Macromolecule methylation is linked to cancer, viral infections such as HIV-1, aging, and metabolic disorders.
What is the methyl donor for macromolecule methylation?
S-adenosylmethionine (SAM) is the primary methyl donor for most enzymatic methylation reactions.
How does folate metabolism affect macromolecule methylation?
Folate metabolism influences one-carbon transfer and methyl donor availability, thereby affecting methylation capacity.
Conclusion
Macromolecule methylation (GO:0043414) is a broad and essential biological process that covalently attaches methyl groups to proteins, nucleic acids, polysaccharides, and other macromolecules. It regulates chromatin compartmentalization, RNA fate, viral replication, and cancer cell biology, making it a high-priority area for mechanistic and therapeutic research. Understanding the genes and pathways involved requires precise experimental models, and CRISPR-based approaches provide the causal resolution needed to move from correlation to function.
References
- 1. Garcia JA et al.. 2024. Biotin-Initiated Poly(oxazoline)s.. Macromolecules 57(13):6354-6361 PMID: 40599896
- 2. Wang L et al.. 2019. Histone Modifications Regulate Chromatin Compartmentalization by Contributing to a Phase Separation Mechanism.. Mol Cell 76(4):646-659.e6 PMID: 31543422
- 3. Papadimitriou MA et al.. 2023. Epi-miRNAs: Modern mediators of methylation status in human cancers.. Wiley Interdiscip Rev RNA 14(2):e1735 PMID: 35580998
- 4. Hamet P et al.. 2003. Genes of aging.. Metabolism 52(10 Suppl 2):5-9 PMID: 14577056
- 5. D'Aimmo MR et al.. 2024. Folate-producing bifidobacteria: metabolism, genetics, and relevance.. Microbiome Res Rep 3(1):11 PMID: 38455078
- 6. Xu G et al.. 2022. Thermoresponsive dendritic oligoethylene glycols.. Phys Chem Chem Phys 24(19):11848-11855 PMID: 35510425
- 7. Decombe A et al.. 2024. Internal RNA 2'-O-methylation on the HIV-1 genome impairs reverse transcription.. Nucleic Acids Res 52(3):1359-1373 PMID: 38015463
- 8. Boriack-Sjodin PA et al.. 2018. RNA-modifying proteins as anticancer drug targets.. Nat Rev Drug Discov 17(6):435-453 PMID: 29773918
